Biogen profit beats on higher Tecfidera sales

(Reuters) - Biogen Inc reported a better-than-expected first-quarter profit helped by higher demand for its key multiple sclerosis (MS) drug, Tecfidera.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro